Catalyst Pharmaceuticals (CPRX) Goodwill & Intangibles (2022 - 2026)

Catalyst Pharmaceuticals has reported Goodwill & Intangibles for 5 years, with the latest figure at $122.0 million in Q1 2026.

• For the quarter ending Q1 2026, Goodwill & Intangibles fell 46.44% year-over-year to $122.0 million; the trailing twelve-month figure through Mar 2026 stood at $122.0 million (down 46.44% YoY), and the FY2025 full-year result was $131.7 million, down 42.18% from the prior year.
• Goodwill & Intangibles for Q1 2026 stood at $122.0 million, down from $131.7 million in the prior quarter.
• The five-year high for Goodwill & Intangibles was $227.7 million in Q2 2024, with the low at $32.5 million in Q4 2022.
• Historically, Goodwill & Intangibles has averaged $166.1 million across 5 years, with a median of $184.1 million in 2023.
• Annual changes were most pronounced in 2023 — Goodwill & Intangibles jumped 497.61% — and 2026, when it sank 46.44%.
• Catalyst Pharmaceuticals' Goodwill & Intangibles stood at $32.5 million in 2022, then jumped by 497.61% to $194.0 million in 2023, then climbed by 17.35% to $227.7 million in 2024, then sank by 42.18% to $131.7 million in 2025, then fell by 7.37% to $122.0 million in 2026.
• The last three Goodwill & Intangibles figures came in at $122.0 million (Q1 2026), $131.7 million (Q4 2025), and $128.6 million (Q3 2025), per Business Quant data.